anti-fungal drugs Flashcards
1. List the prototype drugs used to treat systemic, mucocutaneous, and topical fungal infections, describe their mechanism of action, list their clinical uses, and list their significant side effects.
MOA of flucyosine
inhibits fungal nucleic acid by interfereing with fungal thymidylate
MOA of griseofulvin
inhibits mitosis by binding to tubilin
Polyenes MOA
destabylizes fungal membrane
drugs that inhibit squalene expoxidase
allyl- and benzyl-amines
drugs that inhibit 14 alpha demethylase
Tri-, imid-azoles
MOA of echinocandins
inhibits cell wall synthesis
can cause bone marrow suppression
flucytosine
use of flucytosine
used with Ampotercin B to treat systemic candida and cyptococcal infections
accumultes in keratin precursor cells
griseofulvin,
use of griseofulvin
syperficial mycoses
must be used for 6 months to a year
griseofulvin
SE of griseofulvin
headache, hepatic enzyme induction , and disulfrim reactions
MOA of terbinafine and butenafine
prevent formation of lanosterol by squalene epoxidase inhibition, and produce accumulation of toxic squalene metabolite
accumulates in hair, skin and nails
terbinafine
cures most nail mycoses
terbinafine
SE of terbinafine
GI upset, headache, rare hepatic toxicity
300 hr half life drug
terbinafine
use of butenafine
superficial mycoses
-azole MOA
inhibit 14a demathylase, decreasing ergosterol formation and increasing accumulation of toxic 14a-methyl sterole
inhibits hepatic P450 and can cause drug interactiions
-azole